iGii has secured £22.7 million (about US$30.4 million) in new funding to accelerate the commercialization and industrial adoption of its patented 3D graphene foam, Gii. This follows an earlier £8.8 million raise in 2024, also led by SNIB, which funded scaling of Gii-Sens, the company's diagnostic-sensor component.
iGii has secured £22.7 million (about US$30.4 million) in new funding to accelerate the commercialization and industrial adoption of its patented 3D graphene foam, Gii.
This follows an earlier £8.8 million raise in 2024, also led by SNIB, which funded scaling of Gii-Sens, the company's diagnostic-sensor component.
Gii is a patented, porous 3D graphene foam that iGii says can be produced directly onto any surface at room temperature in seconds, a manufacturing approach designed to avoid the scale-up challenges that...
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
iGii has secured £22.7 million (about US$30.4 million) in new funding to accelerate the commercialization and industrial adoption of its patented 3D graphene foam, Gii. This follows an earlier £8.8 million raise in 2024, also led by SNIB, which funded scaling of Gii-Sens, the company's diagnostic-sensor component. Gii is a patented, porous 3D graphene foam that iGii says can be produced directly onto any surface at room temperature in seconds, a manufacturing approach designed to avoid the scale-up challenges that have historically limited graphene's use in mass-market applications.
Gii is a patented, porous 3D graphene foam that iGii says can be produced directly onto any surface at room temperature in seconds, a manufacturing approach designed to avoid the scale-up challenges that have historically limited graphene's use in mass-market applications.
Open the app view to save this story, compare related coverage, and continue from the same source.